Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Targeted Transcriptional Activation in Plants Using a Potent Dead Cas9-Derived Synthetic Gene Activator.

Li Z, Wang F, Li JF.

Curr Protoc Mol Biol. 2019 Jun;127(1):e89. doi: 10.1002/cpmb.89.

PMID:
31237422
2.

Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress.

Lin J, Fang L, Li H, Li Z, Lyu L, Wang H, Xiao J.

Eur J Pharmacol. 2019 Jun 21;859:172490. doi: 10.1016/j.ejphar.2019.172490. [Epub ahead of print]

PMID:
31229536
3.
4.

Gene disruption through base editing-induced messenger RNA missplicing in plants.

Li Z, Xiong X, Wang F, Liang J, Li JF.

New Phytol. 2019 Apr;222(2):1139-1148. doi: 10.1111/nph.15647. Epub 2019 Jan 24.

PMID:
30565255
5.

New cytosine base editor for plant genome editing.

Li Z, Xiong X, Li JF.

Sci China Life Sci. 2018 Dec;61(12):1602-1603. doi: 10.1007/s11427-018-9416-y. Epub 2018 Nov 11. No abstract available.

PMID:
30474781
6.

PLNR≤20% may be a benefit from PORT for patients with IIIA-N2 NSCLC: a large population-based study.

Shang X, Li Z, Lin J, Wang H, Wang Z.

Cancer Manag Res. 2018 Sep 17;10:3561-3567. doi: 10.2147/CMAR.S173856. eCollection 2018.

7.

Current landscape and future directions of biomarkers for predicting responses to immune checkpoint inhibitors.

Zhu Y, Zhao F, Li Z, Yu J.

Cancer Manag Res. 2018 Aug 7;10:2475-2488. doi: 10.2147/CMAR.S167400. eCollection 2018. Review.

8.

End-of-life chemotherapy is associated with poor survival and aggressive care in patients with small cell lung cancer.

Zhu Y, Tang K, Zhao F, Zang Y, Wang X, Li Z, Sun X, Yu J.

J Cancer Res Clin Oncol. 2018 Aug;144(8):1591-1599. doi: 10.1007/s00432-018-2673-x. Epub 2018 May 29.

PMID:
29845418
9.

The prognostic analysis of different metastatic patterns in extensive-stage small-cell lung cancer patients: a large population-based study.

Cai H, Wang H, Li Z, Lin J, Yu J.

Future Oncol. 2018 Jun;14(14):1397-1407. doi: 10.2217/fon-2017-0706. Epub 2018 Jan 23.

PMID:
29359568
10.

A potent Cas9-derived gene activator for plant and mammalian cells.

Li Z, Zhang D, Xiong X, Yan B, Xie W, Sheen J, Li JF.

Nat Plants. 2017 Dec;3(12):930-936. doi: 10.1038/s41477-017-0046-0. Epub 2017 Nov 20.

11.

Inhibition of HIF-1α by PX-478 suppresses tumor growth of esophageal squamous cell cancer in vitro and in vivo.

Zhu Y, Zang Y, Zhao F, Li Z, Zhang J, Fang L, Li M, Xing L, Xu Z, Yu J.

Am J Cancer Res. 2017 May 1;7(5):1198-1212. eCollection 2017.

12.

Prognostic significance of the lymphocyte-to-monocyte ratio and the tumor-infiltrating lymphocyte to tumor-associated macrophage ratio in patients with stage T3N0M0 esophageal squamous cell carcinoma.

Zhu Y, Li M, Bo C, Liu X, Zhang J, Li Z, Zhao F, Kong L, Yu J.

Cancer Immunol Immunother. 2017 Mar;66(3):343-354. doi: 10.1007/s00262-016-1931-5. Epub 2016 Dec 3.

PMID:
27915370
13.

CD8+/FOXP3+ ratio and PD-L1 expression associated with survival in pT3N0M0 stage esophageal squamous cell cancer.

Zhu Y, Li M, Mu D, Kong L, Zhang J, Zhao F, Li Z, Liu X, Bo C, Yu J.

Oncotarget. 2016 Nov 1;7(44):71455-71465. doi: 10.18632/oncotarget.12213.

14.

A novel RNA-guided RNA-targeting CRISPR tool.

Zhang D, Li Z, Yan B, Li JF.

Sci China Life Sci. 2016 Aug;59(8):854-6. doi: 10.1007/s11427-016-0192-5. Epub 2016 Jul 19. No abstract available.

PMID:
27436421
15.

Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology.

Zhang D, Li Z, Li JF.

J Genet Genomics. 2016 May 20;43(5):251-62. doi: 10.1016/j.jgg.2016.03.001. Epub 2016 Mar 11. Review.

PMID:
27165865
16.

A Healthy Dietary Pattern Reduces Lung Cancer Risk: A Systematic Review and Meta-Analysis.

Sun Y, Li Z, Li J, Li Z, Han J.

Nutrients. 2016 Mar 4;8(3):134. doi: 10.3390/nu8030134. Review.

17.

Kit formulation for preparation and biological evaluation of a novel (99m)Tc-oxo complex with metronidazole xanthate for imaging tumor hypoxia.

Li Z, Lin X, Zhang J, Wang X, Jin Z, Zhang W, Zhang Y.

Nucl Med Biol. 2016 Feb;43(2):165-70. doi: 10.1016/j.nucmedbio.2015.11.001. Epub 2015 Nov 6.

PMID:
26872441
18.

Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation.

Wang S, Su X, Bai H, Zhao J, Duan J, An T, Zhuo M, Wang Z, Wu M, Li Z, Zhu J, Wang J.

J Hematol Oncol. 2015 Nov 12;8:127. doi: 10.1186/s13045-015-0210-9.

19.

Prevalence and clinical significance of BRAF V600E in Chinese patients with lung adenocarcinoma.

Li Z, Jiang L, Bai H, Wang Z, Zhao J, Duan J, Yang X, An T, Wang J.

Thorac Cancer. 2015 May;6(3):269-74. doi: 10.1111/1759-7714.12177. Epub 2015 Apr 24.

20.

Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinoma patients with EGFR mutations.

Wang Z, Shen Z, Li Z, Duan J, Fu S, Liu Z, Bai H, Zhang Z, Zhao J, Wang X, Wang J.

Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):9990-5. doi: 10.1073/pnas.1510837112. Epub 2015 Jul 27.

Supplemental Content

Loading ...
Support Center